Whether in AD Aβ, indeed, enhances tau pathology through mechanisms, such as neurotoxicity or proteostasis and clearance failure, or induces tau aggregation by direct cross‐seeding (or heterologous seeding), needs clarification through further research. Here, MAPT is linked to Alzheimer disease.